We would love to hear your thoughts about our site and services, please take our survey here.
Tempted to take a stake, but no idea how to value AGM or even size the market. Anyone have any bright ideas?
103 what?
I assume the price is only relevant if its connected to some sort of offer or placing, which it isn't in this case.
They'll need to confirm share capital and shares outstanding, plus any other material change to financial position as you say.
I don't think the price will be set within the readmission documents, nice idea though!
OK thanks Keith, hard to say if new price will be lower (given placing/dilution) or higher (reflecting synergies between the two companies), let's hope for the latter!
I forget when the shares relisted, is it November?
Has anyone seen any analyst reports or financial press speculating what the new price may be around?
How do you get to that valuation and 5.8p, not sure I understand?
Market cap 25mn at 50p, given the scale of the opportunity that still seems low. But very difficult to project the revenues or value based on where the company is today. So perhaps somewhat speculative but doesn't seem at all unreasonable.
Itaconix is a good call actually, I have that one too.
Any other similarly valued companies you've bought into Wolololol?
A pump and dump group I suspect, probably spread positive comments all around then reversed. Quite scary how successful it was...
Anyone know what triggered todays volume? Seems funny to suddenly get that kind of spike without a trigger...
RHJoyes - where did you see the news about Frontier Tech investors?
Quite an informative piece. On the negative side they expect additional fundraising and that breakeven won't be achieved until 2013. On a positive side, they highlight a 7-year revenue target of 79mn which although a long distance out highlights some fairly impressive potential given todays market cap.
Not sure we should expect any big rise given the placing was at 1.1p, we're diluted maybe 30% and although we might argue that price is a bargain, it could also be seen to have been agreed as a fair and reasonable price.
Longterm though think we can be pretty confident, even if they only hit 10% of some of the longer term sales targets they mention. So I'd say overall good news despite short term dilution and possibly the minor price drop today.
I guess it's an update but nothing of much commercial relevance in this RNS aside from suggestions of what's in progress.
Doubt this share price will move for months and months but hope I'm wrong!
Anyone know when these will be announced?
I don't think this is the reason, but this came out today I believe
https://markettrendsnews.com/2019/08/critical-limb-ischemia-drug-market-share-2019-by-companies-reneuron-group-plc-symic-biomedical/
What's the link for Docs tweet?
Agree, I'd rather buy more shares than an expensive research report. Be interesting if someone gets hold of a copy though, or if there's any other reaction, eg from brokers.